Advicenne has focused its research on pediatric products (neurology, nephrology) defined as priorities by the European health agencies.

The development of innovative pharmaceutical forms, combined with suitable packaging allowing doses to be adapted to a child’s weight, is an important direction for development aimed at facilitating the administration of the product while minimizing medication errors.

Advicenne has put in place high quality clinical research and developed real pediatric expertise with the aim of registering products destined for children.
For the majority of these products Advicenne will use the PUMA or ORPHAN centralized European procedures.